Insiders who reported open-market trades in the last 12 months at the companies Scott Dreyer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
John A. Fallon - $1.65M in COLL purchases and sales in the last 12 months
Colleen Tupper - $1.22M in COLL purchases and sales in the last 12 months
David Dieter - $716K in COLL purchases and sales in the last 12 months
Garen G. Bohlin - $323K in COLL purchases and sales in the last 12 months
Nancy Lurker - $162K in COLL purchases and sales in the last 12 months
John Gordon Freund - $143K in COLL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Scott Dreyer is a corporate insider, tracked as EVP & Chief Commercial Officer of COLLEGIUM PHARMACEUTICAL, INC (COLL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Scott Dreyer last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 4 filings going back to 2025.
Has Scott Dreyer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($2.83M) across all tracked filings.
Scott Dreyer is EVP & Chief Commercial Officer of COLLEGIUM PHARMACEUTICAL, INC (COLL). 4 SEC Form 4 filings on record going back to 2025, most recently on 5 March 2026. Most recent open-market trade: sold $146K of COLL on 5 March 2026. Lifetime open-market sales: $2.83M.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Scott Dreyer.
InsiderAlpha's records for Scott Dreyer go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. 2 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
